Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News | Antiplatelet and Anticoagulation Therapies

August 16, 2016 — Warfarin prescribed to prevent strokes in atrial fibrillation may not adequately control blood ...

Home August 16, 2016
Home
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC
Feature | Dave Fornell

 


August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional Cardiology ...

Home August 05, 2016
Home
Watchman, left atrial appendage closure, LAA occluder
Feature | Left Atrial Appendage (LAA) Occluders | Dave Fornell

Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...

Home August 01, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

July 26, 2016 — Hematology researchers at The Children’s Hospital of Philadelphia (CHOP) have developed a novel ...

Home July 26, 2016
Home
Technology | Antiplatelet and Anticoagulation Therapies

July 14, 2016 — BBMK Technologies recently announced the launch of ClotMD, a cloud-based application and mobile solution ...

Home July 14, 2016
Home
News | Blood Testing

July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. will be ...

Home July 12, 2016
Home
pros and cons of new anticoagulation therapies, anticoagulants, dabigatran, Pradaxa, novel oral anticoagulants, NOACs, rivaroxaban, Xarelto, apixaban, Eliquis
Feature | Antiplatelet and Anticoagulation Therapies | Heidi Olson, Pharm.D

With the recent introduction of several novel oral anticoagulants (NOACs) on the U.S. market that have been billed by ...

Home July 26, 2016
Home
News | Heart Failure

June 30, 2016 — Researchers at Thomas Jefferson University have discovered how to enhance the effectiveness of beta ...

Home June 30, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

June 24, 2016 — More than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated ...

Home June 24, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

June 2, 2016 — Female atrial fibrillation patients are less likely than their male counterparts to receive blood ...

Home June 02, 2016
Home
News | Antiplatelet and Anticoagulation Therapies

May 25, 2016 — Technavio’s latest report on the U.S. anticoagulants market provides an analysis on the most important ...

Home May 25, 2016
Home
Watchman, left atrial appendage closure, LAA occluder, LAA. LAAO, laa occluder, left atrial appendage, Watchman
Feature | Left Atrial Appendage (LAA) Occluders | Dave Fornell

Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater risk of ...

Home May 20, 2016
Home
News | Atrial Fibrillation

May 19, 2016 — Physician-researchers in the College of Medicine at the University of Cincinnati have developed a ...

Home May 19, 2016
Home
clot, coronary thrombus, antiplatelet therapt, DAPT
Feature | Antiplatelet and Anticoagulation Therapies | Marianne Pop, Pharm.D., BCPS

There were many opinions on the duration of dual antiplatelet therapy (DAPT) highlighted at the 2016 American College of ...

Home May 19, 2016
Home
Feature | Heart Valve Technology

May 16, 2016 — The largest observational study of percutaneous transfemoral transcatheter aortic valve replacement (TAVR ...

Home May 16, 2016
Home
Subscribe Now